Stock Market News
Latest financial news · Updated Jul 17, 2026
My Credit Score Is 760 and I Have $400,000 in Home Equity. The Bank Still Denied My HELOC.
The panel agrees that there's a structural lending gap for retirees with portfolio-derived income, but they're divided on the suitability …
Mizuho Raises PT on Credo Technology (CRDO) After FQ4 2026 Earnings
While CRDO's 157% YoY revenue growth and 68% gross margins are impressive, the panelists express concerns about valuation, customer concentration, …
CoreWeave’s (CRWV) Subsidiary Raises $900 Million Through High Yield Bond Offering, Reports Bloomberg
The panel consensus is bearish on the $900M bond issuance by Elk Grove Village Property LLC for a Chicago hyperscale …
Analysts Bullish on Sandisk (SNDK), Here’s Why
The panel consensus is that the article's bullish thesis on Sandisk (SNDK) is invalid due to the company being acquired …
Stifel Maintains a Buy Rating on Astera Labs (ALAB)
The panelists express caution about ALAB's valuation, with concerns over potential capex cuts by hyperscalers in 2027, reliance on a …
Qnity Electronics (Q) Among Our Best Up and Coming AI Stocks
Qnity's Q1 beat and raised guidance signal strength in AI-related components, but panelists express concerns about margin compression, customer concentration, …
GlobalFoundries (GFS) Forms a Strategic Partnership with the US Department of Energy’s Genesis Mission
The panelists generally agreed that GlobalFoundries' DOE Genesis partnership is a strategic move for long-term ecosystem credibility but has limited …
Mizuho Raises PT on Arm Holdings (ARM), Here’s What You Should Know
Panelists are divided on ARM's future, with concerns about execution, competition, and regulatory risks outweighing optimism about AI demand and …
Mizuho and Citi Raise Western Digital (WDC) Price Targets
The panel has mixed views on Western Digital's (WDC) future, with concerns about hyperscaler vertical integration, HDD-to-SSD crossover, and margin …
ImmunityBio (IBRX): One of the Best Performing Growth Stocks So Far in 2026
The panelists generally agree that IBRX's ASCO presentations, while promising, do not yet validate its IL-15 agonist approach or guarantee …
Truist Raises DELL Price Target to $360, Keeps Hold Rating
Analysts are divided on Dell's price target increase, with some seeing potential in strong AI server demand and supply constraints, …
MaxLinear (MXL) Ranks Among the Best Performing Growth Stocks
The panel consensus is bearish on MaxLinear (MXL), with key concerns being aggressive valuation (65x CY27E P/E), unaddressed execution risks …